Evidence map›Paper›PMID 32635236›Full record

ArticleMicroorganisms2020

William D Rees, Ana C Lorenzo-Leal, Theodore S Steiner, Horacio Bach

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Differential role of M cells in enteroid infection byFrontiers in cellular and infection microbiology · 2024
    Article
  6. Article
  7. ViableMicroorganisms · 2023
    Article
  8. The evidence forTranslational cancer research · 2023
    Review
  9. Article
  10. Drug Targeting of Inflammatory Bowel Diseases by Biomolecules.Nanomaterials (Basel, Switzerland) · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 2 countries.

William D ReesDepartment of Medicine, Division of Infectious Diseases, University of British Columbia, Vancouver, BC V5Z3J5, Canada.ORCID 0000-0002-3171-3068
Ana C Lorenzo-LealDepartment of Medicine, Division of Infectious Diseases, University of British Columbia, Vancouver, BC V5Z3J5, Canada.ORCID 0000-0002-2086-2412
Theodore S SteinerDepartment of Medicine, Division of Infectious Diseases, University of British Columbia, Vancouver, BC V5Z3J5, Canada.
Horacio BachDepartment of Medicine, Division of Infectious Diseases, University of British Columbia, Vancouver, BC V5Z3J5, Canada.
University of British Columbia · CA

Funding

Antibody Engineering and Proteomic Facility N/A
6 · The paper itself

Abstract

background

methodsHuman monocyte-derived dendritic cells (moDCs) were infected with MAP and phagocytosis and intracellular survival were quantified by immunofluorescence (IF) and colony counts, respectively. MoDC cytokine expression was measured via ELISA and their activation state was measured via flow cytometry.

resultsWe showed that MAP can infect and replicate in human moDCs as means to evade the immune system for successful infection, through inhibition of the phago-lysosome fusion via the secretion of protein tyrosine phosphatase PtpA. This mechanism initially led to a state of tolerance in moDCs and then subsequently caused a pro-inflammatory response as infection persisted, characterized by the upregulation of IL-6 and TNFα, and downregulation of IL-10. Moreover, we showed that moDCs have the ability to phagocytose up to 18% of MAP, when exposed at a multiplicity of infection of 1:1.

conclusionInfection and subsequent proliferation of MAP within moDCs could provide a unique means for the dissemination of MAP to lymphoid tissue, while altering immune responses to facilitate the persistence of infection of host tissues in CD.

Indexed as

Crohn’s diseasedendritic cellsJohne’s diseaseMycobacterium avium subspecies paratuberculosisprotein tyrosine phosphatase

Identifiers

PMID32635236
PMCPMC7409171
OpenAlexW3038895516

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.